Tissue transglutaminase autoantibody detection in human saliva: a powerful method for celiac disease screening.
case_control · Level III
Where this comes from
- Record sourced from PubMed, PMID 15126998.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To test the possibility of detecting tissue transglutaminase autoantibodies (tTG-Abs) in saliva with a novel sensitive fluid-phase radioimmunoassay (RIA). Paired saliva and serum samples from 39 patients with celiac disease (CD), at the first biopsy (Group 1: 28 females, mean age 11.5 +/- 11.1 years); 32 controls with a normal duodenal mucosa (Group 2: 18 females, mean age 8.1 +/- 3.6 years); and 32 healthy volunteers (Group 3: 21 females, mean age 31.7 +/- 9.8 years) were studied for tTG-Ab presence. Limit of positivity for salivary assay was calculated according to the 99th percentiles of Group 2 control children and was expressed as an autoantibody (Ab) index. Salivary tTG-Abs were found in 97.4% of the patients with CD and in 100% of the corresponding serum samples. All Group 3 subjects were negative with both saliva and serum assays. A correlation between saliva and serum tTG-Ab titers was found (r=0.826, P=.0014). This study demonstrates that it is possible to detect salivary tTG-Abs in CD with a non-invasive, simple to perform, reproducible and sensitive method.
Medical subject headings
- Autoantibodies
- Celiac Disease
- Transglutaminases